Big acquisition will bring higher earnings

Article Excerpt

MCKESSON CORP. $173 (New York symbol MCK; Aggressive Growth Portfolio, Consumer sector; Shares outstanding: 229.7 million; Market cap: $39.7 billion; Price-to-sales ratio: 0.3; Dividend yield: 0.6%; TSINetwork Rating: Above Average; www.mckesson- .com) has agreed to buy shares of Celesio AG, a German firm that distributes prescription drugs in Europe and Brazil, from its two largest investors. The move will give McKesson about 75% of Celesio. It then plans to buy the remaining 25%. Buying all of Celesio will cost $8.4 billion, including its debt. However, the purchase should add $1.00 to $1.20 a share to McKesson’s annual earnings; it earned $6.33 a share in the fiscal year ended March 31, 2013. McKesson is a buy. buy…